Cost is the top concern GLP-1 users have with their current treatment, followed by side effects and shortage/supply interruptions
This marks the second generic semaglutide approval in Canada, with OneSource supporting both programs - reinforcing the role of integrated partnerships in advancing complex peptide products across regulated markets
Other reactions that occurred at a higher incidence among WEGOVY-treated adult patients included dyspepsia, abdominal pain, abdominal distension, eructation, flatulence, gastroesophageal reflux disease, gastritis, hemorrhoids, and hiccups
Moringa oleifera: a comprehensive review on pharmacology, phytochemistry, and clinical applications
Zepbound, a GLP-1/GIP dual agonist, is also FDA-approved for treating obesity
For example, BPC-157 may provide improved vascularization and collagen production in sites of injury in the musculoskeletal system, while TB-500 may exert anti-inflammatory benefits, further improving the healing process